PFE
Dividend? More like dividend tradition
Pfizer’s board declared a $0.43 fourth-quarter 2026 dividend on its common stock, with payment set for December 7th to shareholders of record as of November 6th. That makes this the company’s 352nd consecutive quarterly dividend — basically the corporate version of never missing leg day.
Why investors care
This isn’t the kind of headline that sends traders sprinting for the exits or the moon. But it does reinforce the big Pfizer pitch: steady cash generation, shareholder returns, and a management team that wants you to think long-term, not meme-stock-minute.
- The dividend stays at $0.43 a share for the quarter.
- Pfizer says it remains committed to maintaining — and, over time, growing — the payout.
- The move lands while the company is still dealing with pipeline updates and fresh legal headaches.
Big picture
When a drugmaker keeps the dividend train running this consistently, it’s signaling confidence in the business’s cash engine. Not flashy, sure. But for income investors, boring can be beautiful.